ATGENOMIX

Atgenomix is a data and machine learning (ML) company that aims to revolutionize healthcare through the operationalization of biomedical data, analytics, and ML. The company offers a cloud-based biomedical informatics platform that enables clinical laboratories to orchestrate multimodal workflows of data integration, analysis automation, and workload acceleration while ensuring regulatory compliance. Founded in 2017 and based in Taiwan, Atgenomix is committed to delivering on the promise of precision medicine.

With a focus on biotechnology, healthcare, information technology, and the internet, Atgenomix envisions leveraging technology to transform routine clinical genomics and artificial intelligence in the healthcare industry. The company aspires to provide accessible computational lab technologies, thus facilitating the scaling of data and machine learning for researchers in the future.

Notably, Atgenomix secured a Series A investment on 01 February 2020, with participation from prominent investors including TransLink Capital, Darwin Venture Management, and Bill Chang. Additionally, the company has established partnerships with industry leaders such as Microsoft Azure and Google Health to further its mission in advancing genomics research.